PRA International Rolls out Client Access to Oracle(R) RDC for Early Phase Studies

By Pra International, PRNE
Thursday, January 14, 2010

Improved Monitoring and Increased Sponsor Access to Data are Key Benefits

RALEIGH, North Carolina, January 15 - PRA International, a leading Clinical Research Organization, announces
that it will begin providing a client-facing portal into Oracle(R) Remote
Data Capture (RDC) for its early phase studies in its Clinical Pharmacology
Units in The Netherlands and the United States. Through the portal, clients
working with PRA will have direct access to review RDC data. The portal
provides sponsors with the ability to review all entered data, to move
between subjects and pages, to see the multiple page views within the system
and to compare separate pages in a side-by-side fashion.

Perhaps the most important benefit from this application is improved
efficiency in study monitoring. A study monitor can monitor remotely either
as a replacement for some site visits or to review data ahead of time in
preparation for a site visit. This results in higher quality data and lower
study costs through the reduction of monitoring time and queries. Other
benefits from this system include the potential for increased client
visibility into any potential safety concerns (via live data review) and
enhanced communication regarding potential data issues between the client and
PRA.

PRA's Early Development Services (EDS) group provides comprehensive
services for phase I and phase IIa studies in healthy volunteers or special
patient populations. Our expertise is primarily with more complex types of
studies in which safety and intelligent design are critical factors.

About PRA International

PRA International conducts clinical trials in more than 75 countries
across 6 continents and provides services through all phases of clinical
development. PRA performs studies in all therapeutic areas, with
specialization in oncology, neurosciences, respiratory/allergy,
cardiovascular and infectious diseases. PRA has supported over 2,100 clinical
trials through its 36+ global offices.

PRA's therapeutic expertise, global reach and project experience,
combined with extensive local knowledge and our differentiating PERSONAL
ELEMENT enable our project teams to deliver consistent and on time
performance for our clients. This unique PRA philosophy - THE PERSONAL
ELEMENT - recognizes that true client service comes only from trained,
empowered and dedicated employees who are encouraged to use innovation and
their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit
www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global
Headquarters at +1-919-786-8200.

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :